SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova’s arm approves proposal for investment in Isharays Energy

29 May 2024 Evaluate

Jubilant Pharmova’s wholly-owned subsidiary -- Jubilant Biosys has approved the proposal for investment including entering into a Power Supply and Offtake Agreement, and Share Subscription and Shareholders Agreement on May 28, 2024 with Isharays Energy Two (Isharays Energy), a wholly-owned subsidiary of SunSource Energy, for acquisition of upto 14.75% stake of Isharays Energy for purchase of renewable energy (electricity) generated from the Captive Generating Plant (CGP).

The company has embarked on a renewable energy implementation journey across its facilities in India to enable reduction in both, cost and carbon footprint. This investment shall enable the company to access renewable energy through captive power arrangement for its facilities located in Noida and Greater Noida. In January this year, the company had approved a similar investment to access renewable power through captive arrangement for its facilities located in Karnataka, India.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.


Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×